201 related articles for article (PubMed ID: 37393343)
1. PHF6 maintains acute myeloid leukemia via regulating NF-κB signaling pathway.
Hou S; Wang X; Guo T; Lan Y; Yuan S; Yang S; Zhao F; Fang A; Liu N; Yang W; Chu Y; Jiang E; Cheng T; Sun X; Yuan W
Leukemia; 2023 Aug; 37(8):1626-1637. PubMed ID: 37393343
[TBL] [Abstract][Full Text] [Related]
2. MiR-1306-5p promotes cell proliferation and inhibits cell apoptosis in acute myeloid leukemia by downregulating PHF6 expression.
Gao X; Fan S; Zhang X
Leuk Res; 2022 Sep; 120():106906. PubMed ID: 35780573
[TBL] [Abstract][Full Text] [Related]
3. PHF6 mutations in adult acute myeloid leukemia.
Van Vlierberghe P; Patel J; Abdel-Wahab O; Lobry C; Hedvat CV; Balbin M; Nicolas C; Payer AR; Fernandez HF; Tallman MS; Paietta E; Melnick A; Vandenberghe P; Speleman F; Aifantis I; Cools J; Levine R; Ferrando A
Leukemia; 2011 Jan; 25(1):130-4. PubMed ID: 21030981
[TBL] [Abstract][Full Text] [Related]
4. PHF6 loss reduces leukemia stem cell activity in an acute myeloid leukemia mouse model.
Yuan S; Gao M; Wang Y; Lan Y; Li M; Du Y; Li Y; Ju W; Huang Y; Yuan K; Zeng L
Cancer Cell Int; 2024 Feb; 24(1):66. PubMed ID: 38336746
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of microRNA-125b inhibits human acute myeloid leukemia cells invasion, proliferation and promotes cells apoptosis by targeting NF-κB signaling pathway.
Wang Y; Tang P; Chen Y; Chen J; Ma R; Sun L
Biochem Biophys Res Commun; 2017 Jun; 488(1):60-66. PubMed ID: 28478034
[TBL] [Abstract][Full Text] [Related]
6. The Role of PHF6 in Hematopoiesis and Hematologic Malignancies.
Eisa YA; Guo Y; Yang FC
Stem Cell Rev Rep; 2023 Jan; 19(1):67-75. PubMed ID: 36008597
[TBL] [Abstract][Full Text] [Related]
7. Aberrant nuclear factor-kappa B activity in acute myeloid leukemia: from molecular pathogenesis to therapeutic target.
Zhou J; Ching YQ; Chng WJ
Oncotarget; 2015 Mar; 6(8):5490-500. PubMed ID: 25823927
[TBL] [Abstract][Full Text] [Related]
8. PHF6 functions as a tumor suppressor by recruiting methyltransferase SUV39H1 to nucleolar region and offers a novel therapeutic target for PHF6-muntant leukemia.
Tsai HI; Wu Y; Huang R; Su D; Wu Y; Liu X; Wang L; Xu Z; Pang Y; Sun C; He C; Shu F; Zhu H; Wang D; Cheng F; Huang L; Chen H
Acta Pharm Sin B; 2022 Apr; 12(4):1913-1927. PubMed ID: 35847518
[TBL] [Abstract][Full Text] [Related]
9. Transient potential receptor melastatin-2 (Trpm2) does not influence murine MLL-AF9-driven AML leukemogenesis or in vitro response to chemotherapy.
Haladyna JN; Pastuer T; Riedel SS; Perraud AL; Bernt KM
Exp Hematol; 2016 Jul; 44(7):596-602.e3. PubMed ID: 27033163
[TBL] [Abstract][Full Text] [Related]
10. Over expression of ubiquitin-conjugating enzyme E2O in bone marrow mesenchymal stromal cells partially attenuates acute myeloid leukaemia progression.
Tian C; Chen Z; Wang L; Si J; Kang J; Li Y; Zheng Y; Gao Y; Nuermaimaiti R; You MJ; Zheng G
Br J Haematol; 2023 Feb; 200(4):476-488. PubMed ID: 36345807
[TBL] [Abstract][Full Text] [Related]
11. Myeloid cell-targeted miR-146a mimic inhibits NF-κB-driven inflammation and leukemia progression in vivo.
Su YL; Wang X; Mann M; Adamus TP; Wang D; Moreira DF; Zhang Z; Ouyang C; He X; Zhang B; Swiderski PM; Forman SJ; Baltimore D; Li L; Marcucci G; Boldin MP; Kortylewski M
Blood; 2020 Jan; 135(3):167-180. PubMed ID: 31805184
[TBL] [Abstract][Full Text] [Related]
12. ZNF460-regulated COMMD7 Promotes Acute Myeloid Leukemia Proliferation Via the NF-κB Signaling Pathway.
Shao X; Zhong L; Chu X; Wan P; Chen S; Zhou Z; Zhang H; Wang M; Liu B
Int J Med Sci; 2023; 20(4):520-529. PubMed ID: 37057209
[TBL] [Abstract][Full Text] [Related]
13. Phf6-null hematopoietic stem cells have enhanced self-renewal capacity and oncogenic potentials.
Hsu YC; Chen TC; Lin CC; Yuan CT; Hsu CL; Hou HA; Kao CJ; Chuang PH; Chen YR; Chou WC; Tien HF
Blood Adv; 2019 Aug; 3(15):2355-2367. PubMed ID: 31395598
[No Abstract] [Full Text] [Related]
14. Investigating the physiological role of S199A and S199D mutants of PHF6 protein in T-cell acute lymphoblastic leukemia.
Erdoğan G; Özeş ON; Küpesiz A; Yoldaş ŞB
Turk J Med Sci; 2023; 53(5):1234-1243. PubMed ID: 38812997
[TBL] [Abstract][Full Text] [Related]
15. Structural and functional insights into the human Börjeson-Forssman-Lehmann syndrome-associated protein PHF6.
Liu Z; Li F; Ruan K; Zhang J; Mei Y; Wu J; Shi Y
J Biol Chem; 2014 Apr; 289(14):10069-83. PubMed ID: 24554700
[TBL] [Abstract][Full Text] [Related]
16. PHF6 mutation is associated with poor outcome in acute myeloid leukaemia.
Huang K; Wang L; Zheng Y; Yue C; Xu X; Chen H; Huang R; Li Y
Cancer Med; 2023 Feb; 12(3):2795-2804. PubMed ID: 36176187
[TBL] [Abstract][Full Text] [Related]
17. Aurora A and NF-κB Survival Pathway Drive Chemoresistance in Acute Myeloid Leukemia via the TRAF-Interacting Protein TIFA.
Wei TW; Wu PY; Wu TJ; Hou HA; Chou WC; Teng CJ; Lin CR; Chen JM; Lin TY; Su HC; Huang CF; Yu CR; Hsu SL; Tien HF; Tsai MD
Cancer Res; 2017 Jan; 77(2):494-508. PubMed ID: 28069801
[TBL] [Abstract][Full Text] [Related]
18. [Role of NF-κB inhibitor in Acute Myeloid Leukemia].
Wang WL; Xu QZ; Mu XH; Wang L; Zhang LY; Xu J; Gao YD; Cheng T; Yuan WP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Dec; 24(6):1622-1626. PubMed ID: 28024466
[TBL] [Abstract][Full Text] [Related]
19. SUV39H1 regulates the progression of MLL-AF9-induced acute myeloid leukemia.
Chu Y; Chen Y; Guo H; Li M; Wang B; Shi D; Cheng X; Guan J; Wang X; Xue C; Cheng T; Shi J; Yuan W
Oncogene; 2020 Dec; 39(50):7239-7252. PubMed ID: 33037410
[TBL] [Abstract][Full Text] [Related]
20. Positive feedback between NF-κB and TNF-α promotes leukemia-initiating cell capacity.
Kagoya Y; Yoshimi A; Kataoka K; Nakagawa M; Kumano K; Arai S; Kobayashi H; Saito T; Iwakura Y; Kurokawa M
J Clin Invest; 2014 Feb; 124(2):528-42. PubMed ID: 24382349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
